Connecting you to content on EBSCOhost

Works by Roth, Sharin E.

Results: 3

1

Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development.

Published in:

Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 333, doi. 10.1002/cpt.1571

By:

Roth, Sharin E.;
Avigan, Mark I.;
Bourdet, David;
Brott, David;
Church, Rachel;
Dash, Ajit;
Keller, Douglas;
Sherratt, Philip;
Watkins, Paul B.;
Westcott‐Baker, Lucas;
Lentini, Silvia;
Merz, Michael;
Ramaiah, Lila;
Ramaiah, Shashi K.;
Stanley, Ann Marie;
Marcinak, John

Publication type:

Article

2

Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach.

Published in:

Toxicological Sciences, 2017, v. 156, n. 2, p. 438, doi. 10.1093/toxsci/kfw269

By:

Mosedale, Merrie;
Yunjung Kim;
Brock, William J.;
Roth, Sharin E.;
Wiltshire, Tim;
Eaddy, J. Scott;
Keele, Gregory R.;
Corty, Robert W.;
Yuying Xie;
Valdar, William;
Watkins, Paul B.

Publication type:

Article

3

Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors.

Published in:

Toxicological Sciences, 2017, v. 155, n. 1, p. 61, doi. 10.1093/toxsci/kfw193

By:

Woodhead, Jeffrey L.;
Brock, William J.;
Roth, Sharin E.;
Shoaf, Susan E.;
Brouwer, Kim L. R.;
Church, Rachel;
Grammatopoulos, Tom N.;
Stiles, Linsey;
Siler, Scott Q.;
Howell, Brett A.;
Mosedale, Merrie;
Watkins, Paul B.;
Shoda, Lisl K. M.

Publication type:

Article